TNF inhibitors are effective not only in BD and AS but also in TAK [138], and the TLR4-mediated expression of IL-1β and IL-1R2 in TAK suggests that, in addition to autoimmunity, autoinflammation may contribute to disease pathogenesis. The gene discussed is TNF; the disease is Behcet disease.